This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
New Immuno-Oncology Solutions (NIOS): Aligning Stakeholders in the Biotech Industry
Vroom, Govert; Maribel Berges; Sastre Boquet, IsaacCase SM-1701-EEntrepreneurship, Innovation and Change, StrategyThis case focuses on a small biotech company (NIOS), located in Barcelona, Spain, that is developing a new immune-oncology product for treating pancreatic cancer. The drug that the company is developing has recently finished Phase I of clinical trials successfully and is now preparing for Phase II and III. At this point, the CEO is approached by her former PhD director, a university professor, who asks if the company is interested in licensing a ...Starting at €8.20
-
Heineken España: Establecimientos temáticos
Llano Irusta, Miguel Angel; Villafuerte, AntonioCase IIST-MI-56Entrepreneurship, Innovation and Change, StrategyEl grupo Heineken a través de la experiencia con los "Iris Pub" de Guiness, se aventura en la creación de restaurantes tematicos ("cambrinus", "Cruz Blanca" y "Beer Station"). Tras los resultados obtenidos, se analiza el plan de futuro de la División de Temáticos. Hasta la fecha, los temáticos no se establecen con un criterio de negocio (no se cobran royalties ni canon de apertura) y se utilizan por el Grupo para crear mercado en zonas donde sus...Starting at €8.20
-
New Immuno-Oncology Solutions (NIOS) - Teaching Note: Aligning stakeholders in the biotech industry
Vroom, Govert; Maribel Berges; Sastre Boquet, IsaacTeaching Note SMT-136-EEntrepreneurship, Innovation and Change, StrategyThis case focuses on a small biotech company (NIOS), located in Barcelona, Spain, that is developing a new immune-oncology product for treating pancreatic cancer. The drug that the company is developing has recently finished Phase I of clinical trials successfully and is now preparing for Phase II and III. At this point, the CEO is approached by her former PhD director, a university professor, who asks if the company is interested in licensing a ...Starting at €0.00